Jackson-Rose Jeannette, Del Monte Judith, Groman Adrienne, Dial Linda S, Atwell Leah, Graham Judy, O'Neil Semler Rosemary, O'Sullivan Maryellen, Truini-Pittman Lisa, Cunningham Terri A, Roman-Fischetti Lisa, Costantinou Eileen, Rimkus Chris, Banavage Adrienne J, Dietz Barbara, Colussi Carol J, Catania Kimberly, Wasko Michelle, Schreffler Kevin A, West Colleen, Siefert Mary Lou, Rice Robert David
Roswell Park Cancer Institute.
Vanderbilt-Ingram Cancer Center.
Clin J Oncol Nurs. 2017 Aug 1;21(4):438-445. doi: 10.1188/17.CJON.438-445.
BACKGROUND: Given the high-risk nature and nurse sensitivity of chemotherapy infusion and extravasation prevention, as well as the absence of an industry benchmark, a group of nurses studied oncology-specific nursing-sensitive indicators. .
OBJECTIVES: The purpose was to establish a benchmark for the incidence of chemotherapy extravasation with vesicants, irritants, and irritants with vesicant potential. .
METHODS: Infusions with actual or suspected extravasations of vesicant and irritant chemotherapies were evaluated. Extravasation events were reviewed by type of agent, occurrence by drug category, route of administration, level of harm, follow-up, and patient referrals to surgical consultation. .
A total of 739,812 infusions were evaluated, with 673 extravasation events identified. Incidence for all extravasation events was 0.09%.
鉴于化疗输注及预防外渗具有高风险性质且对护士敏感，同时缺乏行业基准，一组护士对肿瘤专科护理敏感指标进行了研究。
旨在建立具有发泡剂、刺激剂及具有发泡剂潜能的刺激剂化疗外渗发生率的基准。
对实际发生或疑似发生发泡剂和刺激剂化疗外渗的输注进行评估。通过药物类型、药物类别发生情况、给药途径、伤害程度、随访情况以及患者转外科会诊情况对外渗事件进行审查。
共评估了739,812次输注，确定了673起外渗事件。所有外渗事件的发生率为0.09%。
